Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

by Casadei Gardini, Andrea, Chiadini, Elisa, Faloppi, Luca, Marisi, Giorgia, Delmonte, Angelo, Scartozzi, Mario, Loretelli, Cristian, Lucchesi, Alessandro, Oboldi, Devil, Dubini, Alessandra, Frassineti, Giovanni Luca, Ulivi, Paola
Published in BMC Cancer (2016)

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all...

by Casadei Gardini, Andrea, Puzzoni, Marco, Montagnani, Francesco, Marisi, Giorgia, Tamburini, Emiliano, Cucchetti, Alessandro, Solaini, Leonardo, Foschi, Francesco Giuseppe, Conti, Fabio, Ercolani, Giorgio, Cascinu, Stefano, Scartozzi, Mario
Published in Onco Targets Ther (2019)

Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

by Marisi, Giorgia, Cucchetti, Alessandro, Ulivi, Paola, Canale, Matteo, Cabibbo, Giuseppe, Solaini, Leonardo, Foschi, Francesco G, De Matteis, Serena, Ercolani, Giorgio, Valgiusti, Martina, Frassineti, Giovanni L, Scartozzi, Mario, Casadei Gardini, Andrea
Published in World J Gastroenterol (2018)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

by Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

by Casadei Gardini, Andrea, Foca, Flavia, Scartozzi, Mario, Silvestris, Nicola, Tamburini, Emiliano, Faloppi, Luca, Brunetti, Oronzo, Rudnas, Britt, Pisconti, Salvatore, Valgiusti, Martina, Marisi, Giorgia, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Tassinari, Davide, Cascinu, Stefano, Frassineti, Giovanni Luca
Published in Sci Rep (2017)

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review

by Gardini, Andrea Casadei, Santini, Daniele, Aprile, Giuseppe, Silvestris, Nicola, Felli, Emanuele, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Marisi, Giorgia, Valgiusti, Martina, Passardi, Alessandro, Puzzoni, Marco, Silletta, Marianna, Brunetti, Oronzo, Cardellino, Giovanni Gerardo, Frassineti, Giovanni Luca, Scartozzi, Mario
Published in Oncotarget (2017)

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective...

by Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

by Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin

by De Matteis, Serena, Scarpi, Emanuela, Granato, Anna Maria, Vespasiani-Gentilucci, Umberto, La Barba, Giuliano, Foschi, Francesco Giuseppe, Bandini, Erika, Ghetti, Martina, Marisi, Giorgia, Cravero, Paola, Gramantieri, Laura, Cucchetti, Alessandro, Ercolani, Giorgio, Santini, Daniele, Frassineti, Giovanni Luca, Faloppi, Luca, Scartozzi, Mario, Cascinu, Stefano, Casadei-Gardini, Andrea
Published in Int J Mol Sci (2019)

ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

by Marisi, Giorgia, Petracci, Elisabetta, Raimondi, Francesco, Faloppi, Luca, Foschi, Francesco Giuseppe, Lauletta, Gianfranco, Iavarone, Massimo, Canale, Matteo, Valgiusti, Martina, Neri, Luca Maria, Ulivi, Paola, Orsi, Giulia, Rovesti, Giulia, Vukotic, Ranka, Conti, Fabio, Cucchetti, Alessandro, Ercolani, Giorgio, Andrikou, Kalliopi, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea
Published in Cancers (Basel) (2019)

Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience

by Rovesti, Giulia, Orsi, Giulia, Kalliopi, Andrikou, Vivaldi, Caterina, Marisi, Giorgia, Faloppi, Luca, Foschi, Francesco Giuseppe, Silvestris, Nicola, Pecora, Irene, Aprile, Giuseppe, Molinaro, Eleonora, Riggi, Laura, Ulivi, Paola, Canale, Matteo, Cucchetti, Alessandro, Tamburini, Emiliano, Ercolani, Giorgio, Fornaro, Lorenzo, Andreone, Pietro, Zavattari, Patrizia, Scartozzi, Mario, Cascinu, Stefano, Casadei-Gardini, Andrea
Published in Gastrointest Tumors (2019)

Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort

by Casadei-Gardini, Andrea, Solaini, Leonardo, Riggi, Laura, Molinaro, Eleonora, Dadduzio, Vincenzo, Rizzato, Mario Domenico, Pellino, Antonio, Faloppi, Luca, Marisi, Giorgia, Ulivi, Paola, Canale, Matteo, Orsi, Giulia, Rovesti, Giulia, Andrikou, Kalliopi, Spallanzani, Andrea, Gelsomino, Fabio, Foschi, Francesco Giuseppe, Conti, Fabio, Cucchetti, Alessandro, Ercolani, Giorgio, Biason, Paola, Lonardi, Sara, Cascinu, Stefano, Scartozzi, Mario
Published in Gastrointest Tumors (2019)

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

by Caputo, Francesco, Dadduzio, Vincenzo, Tovoli, Francesco, Bertolini, Giulia, Cabibbo, Giuseppe, Cerma, Krisida, Vivaldi, Caterina, Faloppi, Luca, Rizzato, Mario Domenico, Piscaglia, Fabio, Celsa, Ciro, Fornaro, Lorenzo, Marisi, Giorgia, Conti, Fabio, Silvestris, Nicola, Silletta, Marianna, Lonardi, Sara, Granito, Alessandro, Stornello, Caterina, Massa, Valentina, Astara, Giorgio, Delcuratolo, Sabina, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea
Published in PLoS One (2020)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Clas...

by Casadei-Gardini, Andrea, Montagnani, Francesco, Casadei, Chiara, Arcadipane, Francesca, Andrikou, Kalliopi, Aloi, Deborah, Prete, Alessandra Anna, Zampino, Maria Giulia, Argentiero, Antonella, Pugliese, Giuseppe, Martini, Stefania, Iorio, Giuseppe Carlo, Scartozzi, Mario, Mistrangelo, Massimiliano, Fornaro, Lorenzo, Cassoni, Paola, Marisi, Giorgia, Dell’Acqua, Veronica, Ravenda, Paola Simona, Lonardi, Sara, Silvestris, Nicola, De Bari, Berardino, Ricardi, Umberto, Cascinu, Stefano, Franco, Pierfrancesco
Published in Cancer Manag Res (2019)